The opening of the Gordon Research Conferences – Radionuclide Theranostics for the Management of Cancer
Swiss Rockets AG shared a post on LinkedIn:
“Swiss Rockets News,
Dr. Nadezda Gracheva our Chief Operating Officer of Nuclear Medicine, had the honor of opening the Gordon Research Conferences – Radionuclide Theranostics for the Management of Cancer in July (Newry, Maine, United States).She delivered a compelling presentation on “Terbium-161 for the Next-Generation Novel Radiopharmaceuticals” at the opening event of “Exploring the Power of Radioimmunobiology Via Switching the Radionuclides, Ligands and Immunotargets“, showcasing our latest advancements and insights in nuclear medicine.It was an incredible opportunity to connect with industry leaders, exchange innovative ideas, and contribute to the future of nuclear medicine. A big thank you to the conference organizers and to everyone who attended.”
Nadezda Gracheva,Elcin Zan, MD Ken Herrmann, Oluwatayo Ikotun, Ulli Köster, Dr. Vladimir Cmiljanovic, Natasa, Doriano Fabbro, Milan Crnogorac, Bruno Osterwalder, Thomas Staehelin ,André Debrunner, Claudia Daubenberger, Christoph Tschumi, Dr. Thomas Ladner, Christoph Brutschin, Marcel Tanner, Daniel Gutenberg, Hans-Jörg Fankhauser and Zeljko Mirkovic PhD
Source: Swiss Rockets AG/LinkedIn